Reports and Royalty Payment. Royalties shall be calculated and reported for each calendar quarter and shall be paid within […***…] after the end of each calendar quarter. Each payment shall be accompanied by a report of Net Sales of Products by Amgen, its Affiliates and Sublicensees in sufficient detail to permit confirmation of the accuracy of the royalty payment made, including, without limitation and on a country-by-country basis (or, where the Amgen Finance Department does not track information relating to the calculation of Net Sales on a country-by-country basis, on a region-by-region basis): (i) Net Sales, applicable royalty rates, and the amount of royalties payable hereunder; and (ii) such information as the Amgen Finance Department tracks for the purpose of calculating Net Sales, applicable royalty rates, and the royalties payable hereunder, including (to the extent so tracked) gross sales, applicable royalty adjustments, the amount of any applicable credits taken against royalties, the royalties payable, the method used to calculate the royalties payable, and the exchange rates used.
Reports and Royalty Payment. Within sixty (60) days after the end of each Calendar Quarter during which there are Net Sales giving rise to a payment obligation of a Royalty Payment, a Party owing a Royalty Payment pursuant to Section 6.3.1 or 6.3.2 above (a “Paying Party”) shall deliver to the other Party a report setting out, for each Collaboration Product on a country-by-country basis, the following:
(a) gross sales of Collaboration Products in the Field in such country during the relevant Calendar Quarter;
(b) Net Sales of Collaboration Products in the Field in such country during the relevant Calendar Quarter;
(c) all relevant deductions in accordance with Section 1.45 and this Section 6.3.6; and
(d) all relevant exchange rate conversions; and
(e) Any amounts due under this Section 6.3 for such Calendar Quarter shall accompany such report.
Reports and Royalty Payment. Commencing with the first Quarter in which the first Launch of a Product occurs, and for each Quarter thereafter for so long as Amicus owes a royalty to GSK under Section 7.1(b), Amicus shall, within ****** after the end of the applicable Quarter, submit to GSK, together with Amicus’ payment for the royalties due under Section 7.1(b) for each Quarter, a written report showing the actual Net Sales and the royalties due, in each case in U.S. dollars. Such report shall be in the format reasonably requested by GSK, including any such information regarding the Net Sales of such Products and calculation of such royalties. Amicus will also provide to GSK, on a quarterly basis following the Launch of a Co-Formulation Product, a report showing any royalties due to JCR under Section 7.1(b)(iv)(c), together with payment of any royalties due.
Reports and Royalty Payment. Within sixty (60) days after the end of each calendar quarter, Apollo shall deliver to Inovio a report setting out in reasonable detail the information necessary to calculate the royalty payments due under this Section 6.3 with respect to Net Sales made in that calendar quarter, including:
(i) units of the Product sold in the Territory during the relevant calendar quarter on a country-by-country basis;
(ii) gross sales of the Product in the Territory in the relevant calendar quarter on a country-by-country basis;
(iii) Net Sales in the relevant calendar quarter;
(iv) all relevant deductions or credits due to Apollo in accordance with the terms of this Agreement; and
(v) all relevant exchange rate conversions in accordance with Section 7.2. Any amounts due under Section 6.3(a) for such calendar quarter shall follow up such statement.
Reports and Royalty Payment. Within [… * …], GSK shall send to XenoPort a written report with respect to the preceding calendar quarter, stating the gross invoiced sales for Product, a top-line summary of the deductions specified in Section 1.36 taken from gross sales and the Net Sales in the Territory during such calendar quarter in United States dollars (each, a “Payment Report”). Royalties will be calculated based on the Payment Report. GSK shall pay the appropriate royalties set forth in the Payment Report within [… * …]
Reports and Royalty Payment. Thereafter GSK shall, within ****** after the end of each Quarter, submit to Amicus, together with GSK’s payment for the royalties due for each Quarter, on a Product-by-Product and country-by-country basis, a written report (an “Actual Payment Report”) showing the actual Net Sales and the royalties payable in accordance with Section 3.4 in each case in U.S. dollars. In each country where Net Sales have occurred in a currency other than United States dollars, such Net Sales will be converted to United States Dollars in accordance with Section 3.7 above.
Reports and Royalty Payment. During the Term of this Agreement, following the first commercial sale of the Product within the GSK Territory, within [**] after the end of each Calendar Quarter, GSK shall deliver to Sepracor a report setting out (on a country by country basis and in the aggregate) Net Sales in the relevant Calendar Quarter and all exchange rate conversions in accordance with Section 8.2(b). In addition, in such report GSK shall set out for [**]:
(i) units of the Product sold during the relevant Calendar Quarter;
(ii) gross sales figure of the Product in the relevant Calendar Quarter; and
(iii) a summary of deductions made in accordance with Sections 1.31 and 7.3(c). All payment amounts due under Section 7.3(a) for such Calendar Quarter shall accompany such statement.
Reports and Royalty Payment. Within [...
Reports and Royalty Payment. During the Term, within thirty (30) days after the end of each Calendar Quarter, Partner shall deliver to Optimer a report setting forth (on a country-by-country basis and in the aggregate) the gross sales of Products and Net Sales in the relevant Calendar Quarter, any exchange rate conversion in accordance with Section 7.3, and a calculation of the payments due under Section 6.3, including the applicable royalty rate applied in calculating such payments (a “Royalty Report”). Following receipt of any Royalty Report Optimer shall raise an invoice for the amount stated by Partner to be payable to Optimer in such Royalty Report. Payment shall be due from Partner within thirty (30) days of its receipt of such an invoice.
Reports and Royalty Payment. Within ten (10) Business Days after the end of each calendar quarter, Shire shall deliver to Amicus a report setting out all details necessary to calculate the royalty payments due under this Section 7.3 with respect to Net Sales made in that calendar quarter, including:
(a) units of Licensed Products sold in the Shire Territory during the relevant calendar quarter [***];
(b) gross sales of Licensed Products in the Shire Territory in the relevant calendar quarter [***], including the gross sales price of each Licensed Product;
(c) Net Sales of Licensed Products in the relevant calendar quarter on a country-by-country basis;
(d) all relevant deductions in accordance with Section 1.25 and this Section 7.3;
(e) all relevant exchange rate conversions; and
(f) such other information as requested by Amicus regarding the Commercialization of Licensed Products in the Shire Territory as necessary to satisfy Amicus’ reporting obligations to its licensors under the Existing In-Licenses. Any amounts due under this Section 7.3 for such calendar quarter shall be paid within thirty (30) days after the end of such calendar quarter.
